Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 7
Submit an article Journal homepage
233
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries

Pierre Emmanuel Paradis Groupe d’analyse, Ltée, Montréal, Québec, Canada
,
Dominick Latrémouille-Viau Groupe d’analyse, Ltée, Montréal, Québec, Canada
,
Yuliya Moore Groupe d’analyse, Ltée, Montréal, Québec, Canada
,
Natalia Mishagina Groupe d’analyse, Ltée, Montréal, Québec, Canada
,
Marie-Hélène Lafeuille Groupe d’analyse, Ltée, Montréal, Québec, Canada
,
Patrick Lefebvre Groupe d’analyse, Ltée, Montréal, Québec, Canada
,
Maren Gaudig Janssen-Cilag Germany, Neuss, Germany
&
Mei Sheng Duh Analysis Group, Inc., Boston, MA, USACorrespondence[email protected]
 show all
Pages 1793-1805 | Accepted 15 May 2009, Published online: 05 Jun 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Josemir W Sander, Philippe Ryvlin, Hermann Stefan, Daniel R Booth & Jürgen Bauer. (2010) Generic substitution of antiepileptic drugs. Expert Review of Neurotherapeutics 10:12, pages 1887-1898.
Read now

Articles from other publishers (11)

Valeria Belleudi, Francesco Trotta, Simona Vecchi, Laura Amato, Antonio Addis & Marina Davoli. (2018) Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review. Journal of Clinical Epidemiology 101, pages 5-16.
Crossref
Patrick Kwan & André Palmini. (2017) Association between switching antiepileptic drug products and healthcare utilization: A systematic review. Epilepsy & Behavior 73, pages 166-172.
Crossref
William V. Padula, Richard A. Larson, Stacie B. Dusetzina, Jane F. Apperley, Rudiger Hehlmann, Michele Baccarani, Ekkehard Eigendorff, Joelle Guilhot, Francois Guilhot, Rudiger Hehlmann, Francois-Xavier Mahon, Giovanni Martinelli, Jiri Mayer, Martin C. Müller, Dietger Niederwieser, Susanne Saussele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson & Rena M. Conti. (2016) Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States. Journal of the National Cancer Institute 108:7, pages djw003.
Crossref
Rena M. Conti, William V. Padula & Richard A. Larson. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia 231 255 .
Rena M. Conti, William V. Padula & Richard A. Larson. (2015) Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU. Annals of Hematology 94:S2, pages 249-257.
Crossref
Ceri J Phillips. (2013) A health economic perspective on generic therapeutic substitution. European Journal of Hospital Pharmacy 20:5, pages 290-292.
Crossref
Ripple Talati, Jennifer M. Scholle, Olivia P. Phung, Erika L. Baker, William L. Baker, Ajibade Ashaye, Jeffrey Kluger, Craig I. Coleman & C. Michael White. (2012) Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:4, pages 314-322.
Crossref
Julie Eve Desmarais, Linda Beauclair & Howard C. Margolese. (2011) Switching from Brand-Name to Generic Psychotropic Medications: A Literature Review. CNS Neuroscience & Therapeutics 17:6, pages 750-760.
Crossref
Stephanie J. Phelps. (2010) A Patient's Voice. The Journal of Pediatric Pharmacology and Therapeutics 15:2, pages 66-67.
Crossref
A. Carius & A. Schulze-Bonhage. (2010) Umstellungen zwischen Lamotrigin-Präparaten bei EpilepsiepatientenChanging lamotrigine preparations in epilepsy patients. Der Nervenarzt 81:4, pages 423-434.
Crossref
. (2013) Generic entry of topiramate comes at a cost. PharmacoEconomics & Outcomes News 584:1, pages 5-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.